// App-Quantinova.ai

e20531 : Continuation of epidermal growth factor tyrokine kinase inhibitor with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients.

Researchers

Presenter

  • Ling Peng

Principal Investigators

  • Qiong Zhao

  • Yina Wang

  • Haibo Mou

  • Yemin Tang

  • Danna Hu

  • Lei Zeng

  • Bo Zhao

Medical Centers

  • Department of Thoracic Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • NCT01998061

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved